Guardant Health (GH) Equity Average (2018 - 2025)
Guardant Health (GH) has disclosed Equity Average for 8 consecutive years, with -$226.9 million as the latest value for Q4 2025.
- Quarterly Equity Average fell 127.18% to -$226.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$226.9 million through Dec 2025, down 127.18% year-over-year, with the annual reading at -$119.5 million for FY2025, 1355.21% down from the prior year.
- Equity Average hit -$226.9 million in Q4 2025 for Guardant Health, up from -$330.0 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $1.1 billion in Q1 2021 to a low of -$330.0 million in Q3 2025.
- Historically, Equity Average has averaged $213.0 million across 5 years, with a median of $118.8 million in 2023.
- Biggest five-year swings in Equity Average: soared 1352.23% in 2024 and later tumbled 969.45% in 2025.
- Year by year, Equity Average stood at $677.2 million in 2021, then tumbled by 83.25% to $113.5 million in 2022, then soared by 70.53% to $193.5 million in 2023, then plummeted by 151.62% to -$99.9 million in 2024, then tumbled by 127.18% to -$226.9 million in 2025.
- Business Quant data shows Equity Average for GH at -$226.9 million in Q4 2025, -$330.0 million in Q3 2025, and -$278.1 million in Q2 2025.